Genome editing: US could apply UK's approach to evaluate safety, ethics

Two potential ways of stamping out serious disease by manipulating the genomes of human embryos are under intense public debate: mitochondrial replacement therapy and germline genome editing. The UK has already approved the former. Its process could guide the US as it considers allowing either or both of the techniques.
Source: ScienceDaily Headlines - Category: Science Source Type: news